Tips for Deviation & Failure Case Studies

The scenario unfolded in a sterile injectable manufacturing facility where preparations were underway for an FDA regulatory inspection. During a routine internal audit, a deviation from a validation protocol was…

The first indicators of a process deviation often come from observations on the floor or within the laboratory environment. In this case, several symptoms prompted the quality team to investigate…

In our scenario, a batch of a sterile product was found to exhibit inconsistent results during stability testing post-requalification. The following symptoms signaled a potential issue: Click to read the…

During routine internal quality assessments, the Quality Control (QC) team noted discrepancies in documentation relating to the equipment qualification of a critical piece of manufacturing machinery, specifically a high-throughput liquid…

During a routine internal audit of a sterile manufacturing facility, several symptoms indicating potential validation deficiencies were identified. These included:Click to read the full article.

The first signs of the issue usually manifested as findings during routine internal audits. The Quality Assurance (QA) team identified that several batches processed using the affected equipment had deviations…

The initial indication of potential CSV misalignment began with an FDA inspection, during which inspectors observed discrepancies between the validation documents and the actual operational practices of a critical software…

Case Study: Incomplete Equipment Qualification During Change Control and Its Implications In the world of pharmaceutical manufacturing, ensuring that all systems and processes are fully validated is critical for compliance…

Exploring an Inspection Outcome: A Case Study on Ignored Validation Protocol Deviations In a recent regulatory inspection, a pharmaceutical manufacturing facility faced significant scrutiny due to an unresolved validation protocol…

During a scheduled internal quality audit, the quality assurance (QA) team identified that requalification documentation for several critical pieces of equipment was missing or beyond their validity period. The following…

During a recent FDA inspection, a pharmaceutical manufacturer faced a significant compliance issue when inspectors identified that a process had undergone a significant change without the requisite revalidation. This oversight…

In the lead-up to an anticipated FDA inspection, a manufacturing site noticed discrepancies in the results from two consecutive PPQ runs. A subsequent internal audit revealed modifications to the acceptance…